What constitutes best medical therapy for peripheral arterial disease?

被引:22
作者
Burns, P [1 ]
Lima, E [1 ]
Bradbury, AW [1 ]
机构
[1] Univ Birmingham, Birmingham Heartlands Hosp, Lincoln House Res Inst, Dept Vasc Surg, Birmingham B9 5SS, W Midlands, England
关键词
best medical therapy; peripheral arterial disease;
D O I
10.1053/ejvs.2002.1684
中图分类号
R61 [外科手术学];
学科分类号
摘要
Peripheral arterial disease (PAD) is associated with a high morbidity and mortality, largely from coronary and cerebrovascular disease, which often overshadows the PAD itself. Best Medical Therapy (BMT), comprising smoking cessation, antiplatelet agent use, cholesterol reduction, exercise therapy, and the diagnosis and treatment of hypertension and diabetes mellitus; is evidenced based and call result in significant reductions in cardiovascular risk, as well as some improvement in PAD. Previous data have largely been restricted to patients with coronary artery disease, and their relevance to PAD has been extrapolated. However, data are now starting to become available, such as the Heart Protection Study, with data specific to PAD patients. This article reviews the data regarding the use of BMT in patients with PAD, and based oil this, makes recommendations for the use of BMT in this group of patients.
引用
收藏
页码:6 / 12
页数:7
相关论文
共 73 条
  • [1] ABBOT NC, 2000, COCHRANE DATABASE SY
  • [2] Diabetes and peripheral vascular disease
    Akbari, CM
    LoGerfo, FW
    [J]. JOURNAL OF VASCULAR SURGERY, 1999, 30 (02) : 373 - 384
  • [3] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [4] Anand SS, 1999, CAN J CARDIOL, V15, P1259
  • [5] [Anonymous], 1998, Heart, V80 Suppl 2, pS1
  • [6] [Anonymous], COCHRANE DATABASE SY
  • [7] [Anonymous], 1999, BMJ-BRIT MED J, V318, P29
  • [8] [Anonymous], COCHRANE DATABASE SY
  • [9] MULTICENTER DOUBLE-BLIND-STUDY OF TICLOPIDINE IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND THE PREVENTION OF ITS COMPLICATIONS
    ARCAN, JC
    BLANCHARD, J
    BOISSEL, JP
    DESTORS, JM
    PANAK, E
    [J]. ANGIOLOGY, 1988, 39 (09) : 802 - 811
  • [10] BAINTON D, 1994, BRIT HEART J, V72, P128